Asparatame: An Overview of the FDA Health Concerns
Since the 1970's, the FDA Has Monitored Asparatame Without Much Influence
By Christine Cadena, published Jul 06, 2006
Published Content: 3,275 Total Views: 1,955,454 Favorited By: 82 CPs
Discovered in 1965 by G.D. Searle, asparatame was approved for consumer use in 1974 under limited use by the FDA. Unfortunately, following the 1974 approval, the FDA learned Searle may have hidden testing evidence with regard to the risks of asparatame. In reviewing those prior testing results, the FDA found the studies revealed tumor development in test species which had been later cut out, discovered some test species were later found dead and unreported and studies which exhibited asparatame’s breakdown process may be a catalyst in the creation of uterine tumors. However, following discovery of the discrepancies, in 1981, the FDA continued to approve asparatame for dry foods and, then again in 1983, it was approved for soft drink use.
Unfortunately, through the years of research, asparatame was shown to be attributed no only to the test related health implications but may also be attributed to cancer, hair loss, depression, behavioral disturbances and even dementia.
You may also like...
- Health Implications of Chocolate: The Flavonoid Overview
- Traveling to Ecuador; Understanding the Health Implications of Travel
- Health Implications of Tuna Fish
- Hydrocodone: Overuse Can Lead to Abuse and Health Complications
- Beat the Low Carb Blues; An Overview of the Niacin Implications
- Vaginal Douching: Health Risks Associated with Repeat Gynecological Hygiene
- Thong Wearing is a Health Risk
- Vitamin E: The Natural Method to Promote Immune and Cardiovascular Health
- Percocet and the Chronic Pain Patient
- Older Diabetics Have More Chronic Health Problems
Did You Know?
The FDA did not approve asparatame for soft drinks until 1983.
Resources
Comments
Type in Your Comments Below - (1000 characters left)
Most Commented On

